Edit |   |
---|---|
Antigenic Specificity | Clivatuzumab (biosimilar) |
Clone | monoclonal |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | IgG1 kappa |
Format | purified |
Size | 5 mg, 1 mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Yttrium (90Y) clivatuzumab tetraxetan (trade name hPAM4-Cide) is a humanized monoclonal antibody-drug conjugate designed for the treatment of pancreatic cancer. The antibody part, clivatuzumab (targeted at MUC1), is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells. |
Immunogen | n/a |
Other Names | hPAM4, hPAM4 IgG-DOTA, hPAM4-DOTA |
Gene, Accession # | n/a |
Catalog # | orb1140941 |
Price | $4317 |
Order / More Info | Clivatuzumab (biosimilar) Antibody from BIORBYT LTD. |
Product Specific References | n/a |
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558